HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,870 | +5.2% | 32,051 | +0.1% | 0.16% | +13.9% |
| Q2 2023 | $2,727 | -11.2% | 32,019 | -13.7% | 0.14% | 0.0% |
| Q1 2023 | $3,071 | +54.4% | 37,123 | +46.8% | 0.14% | +42.7% |
| Q4 2022 | $1,989 | -99.9% | 25,286 | -0.4% | 0.10% | +5.5% |
| Q3 2022 | $1,880,000 | -27.2% | 25,391 | -12.0% | 0.09% | +28.2% |
| Q2 2020 | $2,584,000 | +263.4% | 28,852 | +304.8% | 0.07% | +238.1% |
| Q1 2020 | $711,000 | -92.1% | 7,128 | -92.1% | 0.02% | -89.2% |
| Q4 2018 | $9,002,000 | +27.6% | 89,968 | +46.1% | 0.19% | +55.2% |
| Q3 2018 | $7,056,000 | +80.9% | 61,576 | +41.6% | 0.12% | +86.6% |
| Q2 2018 | $3,900,000 | +389900.0% | 43,489 | +621171.4% | 0.07% | – |
| Q1 2018 | $1,000 | – | 7 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |